Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial

2020 ◽  
Author(s):  
Emmanouil Papasavvas ◽  
Livio Azzoni ◽  
Amelie Pagliuzza ◽  
Mohamed Abdel-Mohsen ◽  
Brian N. Ross ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Pegylated interferon alpha 2b for chronic hepatitis C

2009 ◽  
Author(s):  
Tahany Awad ◽  
Kristian Thorlund ◽  
Goran Hauser ◽  
Mahasen Mabrouk ◽  
Davor Stimac ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia

2003 ◽  
Vol 51 (1) ◽  
pp. 81-86 ◽  
Author(s):  
Yesid Alvarado ◽  
Jorge Cortes ◽  
Srdan Verstovsek ◽  
Deborah Thomas ◽  
Stephan Faderl ◽  
...  
Keyword(s):  
Pilot Study ◽  
Interferon Alpha ◽  
Essential Thrombocythemia ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir

2014 ◽  
Vol 44 (10) ◽  
pp. E84-E91 ◽  
Author(s):  
Hisashi Ishida ◽  
Sadatsugu Sakane ◽  
Takashi Toyama ◽  
Keisuke Fukutomi ◽  
Keiichi Kimura ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Interferon Alpha ◽  
Low Dose ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B ◽  
Epoetin Alpha
Sign in / Sign up

Export Citation Format

Share Document